Literature DB >> 26660446

Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.

Haiyan S Li1, Jin Jin1, Xiaoxuan Liang1, Katie A Matatall2, Ying Ma1, Huiyuan Zhang1, Stephen E Ullrich1,3, Katherine Y King2, Shao-Cong Sun1,3, Stephanie S Watowich1,3.   

Abstract

Heterozygous mutations in the transcriptional regulator GATA-2 associate with multilineage immunodeficiency, myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). The majority of these mutations localize in the zinc finger (ZnF) domains, which mediate GATA-2 DNA binding. Deregulated hematopoiesis with GATA-2 mutation frequently develops in adulthood, yet GATA-2 function in the bone marrow remains unresolved. To investigate this, we conditionally deleted the GATA-2 C-terminal ZnF (C-ZnF) coding sequences in adult mice. Upon Gata2 C-ZnF deletion, we observed rapid peripheral cytopenia, bone marrow failure, and decreased c-Kit expression on hematopoietic progenitors. Transplant studies indicated GATA-2 has a cell-autonomous role in bone marrow hematopoiesis. Moreover, myeloid lineage populations were particularly sensitive to Gata2 hemizygosity, while molecular assays indicated GATA-2 regulates c-Kit expression in multilineage progenitor cells. Enforced c-Kit expression in Gata2 C-ZnF-deficient hematopoietic progenitors enhanced myeloid colony activity, suggesting GATA-2 sustains myelopoiesis via a cell intrinsic role involving maintenance of c-Kit expression. Our results provide insight into mechanisms regulating hematopoiesis in bone marrow and may contribute to a better understanding of immunodeficiency and bone marrow failure associated with GATA-2 mutation.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  GATA-2 mutation; c-Kit; hematopoiesis; myelopoiesis

Mesh:

Substances:

Year:  2016        PMID: 26660446      PMCID: PMC5680037          DOI: 10.1111/ejh.12719

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  36 in total

1.  C/EBPα is required for development of dendritic cell progenitors.

Authors:  Robert S Welner; Deepak Bararia; Giovanni Amabile; Akos Czibere; Touati Benoukraf; Christian Bach; K Disnika Senali Abayratna Wansa; Min Ye; Hong Zhang; Tadafumi Iino; Christopher J Hetherington; Koichi Akashi; Daniel G Tenen
Journal:  Blood       Date:  2013-04-01       Impact factor: 22.113

2.  GATA2 and Sp1 positively regulate the c-kit promoter in mast cells.

Authors:  Keiko Maeda; Chiharu Nishiyama; Hideoki Ogawa; Ko Okumura
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

Review 3.  Role of c-Kit and erythropoietin receptor in erythropoiesis.

Authors:  Veerendra Munugalavadla; Reuben Kapur
Journal:  Crit Rev Oncol Hematol       Date:  2005-04       Impact factor: 6.312

Review 4.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Alternative promoters regulate transcription of the mouse GATA-2 gene.

Authors:  N Minegishi; J Ohta; N Suwabe; H Nakauchi; H Ishihara; N Hayashi; M Yamamoto
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

6.  Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function.

Authors:  Michael A Charles; Thomas L Saunders; William M Wood; Kailey Owens; A F Parlow; Sally A Camper; E C Ridgway; David F Gordon
Journal:  Mol Endocrinol       Date:  2006-03-16

7.  High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle.

Authors:  Alex J Tipping; Cristina Pina; Anders Castor; Dengli Hong; Neil P Rodrigues; Lorenza Lazzari; Gillian E May; Sten Eirik W Jacobsen; Tariq Enver
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

8.  GATA-2 regulates granulocyte-macrophage progenitor cell function.

Authors:  Neil P Rodrigues; Ashleigh S Boyd; Cristina Fugazza; Gillian E May; Yanping Guo; Alex J Tipping; David T Scadden; Paresh Vyas; Tariq Enver
Journal:  Blood       Date:  2008-10-07       Impact factor: 22.113

9.  Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow.

Authors:  P A Koni; S K Joshi; U A Temann; D Olson; L Burkly; R A Flavell
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

Review 10.  Haematopoietic and immune defects associated with GATA2 mutation.

Authors:  Matthew Collin; Rachel Dickinson; Venetia Bigley
Journal:  Br J Haematol       Date:  2015-02-23       Impact factor: 6.998

View more
  4 in total

Review 1.  Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.

Authors:  Taylor T Chrisikos; Yifan Zhou; Natalie Slone; Rachel Babcock; Stephanie S Watowich; Haiyan S Li
Journal:  Mol Immunol       Date:  2018-03-15       Impact factor: 4.407

2.  Analysis of microRNA expression profiles in exosomes derived from acute myeloid leukemia by p62 knockdown and effect on angiogenesis.

Authors:  Chuan Li; Xinyi Long; Peiqi Liang; Zhuogang Liu; Chen Wang; Rong Hu
Journal:  PeerJ       Date:  2022-07-22       Impact factor: 3.061

3.  Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia.

Authors:  Juan Bautista Menendez-Gonzalez; Milica Vukovic; Ali Abdelfattah; Lubaid Saleh; Alhomidi Almotiri; Leigh-Anne Thomas; Aloña Agirre-Lizaso; Aleksandra Azevedo; Ana Catarina Menezes; Giusy Tornillo; Sarah Edkins; Kay Kong; Peter Giles; Fernando Anjos-Afonso; Alex Tonks; Ashleigh S Boyd; Kamil R Kranc; Neil P Rodrigues
Journal:  Stem Cell Reports       Date:  2019-08-01       Impact factor: 7.765

4.  Uncoupling key determinants of hematopoietic stem cell engraftment through cell-specific and temporally controlled recipient conditioning.

Authors:  Natsumi Miharada; Anna Rydström; Justyna Rak; Jonas Larsson
Journal:  Stem Cell Reports       Date:  2021-06-24       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.